Zinger Key Points
- Microvast stock drops after delaying Form 10-K filing due to internal reporting issues.
- The delay is caused by the need for additional time to assess internal controls and asset valuation.
- Next: Get access to a new market-moving chart every day featuring a stock flashing clear technical signals. See today's pick now.
Microvast Holdings Inc. MVST shares are trading lower Wednesday after the company announced a delay in filing its Form 10-K for the fiscal year ended Dec. 31 2024.
What To Know: The company explained it could not file the report on time because it needed additional time to complete its year-end closing and financial reporting process. This includes finishing an assessment of the effectiveness of its internal control over financial reporting.
Microvast is also still conducting an asset valuation for its facility in Clarksville, Tennessee, which is contributing to the delay.
The company's status as an emerging growth company ended on Dec. 31, 2024, requiring it to comply with auditor attestation requirements under Section 404 of the Sarbanes-Oxley Act. These additional requirements have made the filing process more complex. Microvast stated the delay could not be avoided without unreasonable effort or expense, meaning it would miss the prescribed filing deadline.
How To Buy MVST Shares?
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock, or creating a strategy for your 401(k) that would acquire shares in a mutual fund or another instrument.
For example, in Microvast Holdings’ case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track the sector, allowing an investor to gain exposure to the trends within that segment.
MVST Price Action: Microvast shares closed down Wednesday by 11.19% at $1.27, according to Benzinga Pro.

Read Next:
Photo: Shutterstock.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.